RESEARCH PAPER

Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison

Simone Neubauer¹, Robert Welte¹, Alexandra Beiche², Hans-Helmut Koenig³, Katharina Buesch¹ and Reiner Leidl¹

¹ GSF-National Research Center for Environment and Health, Institute of Health Economics and Health Care Management, Neuherberg, Germany
² Department of Surgery, General Hospital Laupheim, Laupheim, Germany
³ Health Economics Research Unit, Department of Psychiatry, University of Leipzig, Leipzig, Germany

Correspondence to:
Correspondence to:
S Neubauer
GSF-National Research Center for Environment and Health, Institute of Health Economics and Health Care Management, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany; simone.neubauer{at}gsf.de

Objective: To assess the negative health consequences and associated costs of cigarette smoking in Germany in 2003 and to compare them with the respective results from 1993.

Methods: The number of deaths, years of potential life lost (YPLL), direct medical and indirect costs caused by active cigarette smoking in Germany in 2003 is estimated from a societal perspective. The method is similar to that applied by Welte et al, who estimated the cost of smoking in Germany in 1993. Therefore, a direct comparison of the results was possible. Methodological and data differences between these two publications and their effect on the results are analysed.

Results: In 2003, 114 647 deaths and 1.6 million YPLL were attributable to smoking. Total costs were 21.0 billion, with 7.5 billion for acute hospital care, inpatient rehabilitation care, ambulatory care and prescribed drugs; 4.7 billion for the indirect costs of mortality; and 8.8 billion for costs due to work loss days and early retirement. From 1993 to 2003, the proportionate mortality attributable to smoking remained relatively stable, rising from 13.0% to 13.4%. The smoking-attributable deaths in men is lowered by 13.7% whereas that in women increased by 45.3%. Total real direct costs rose by 35.8%, and total real indirect costs declined by 7.1%, rendering an increase of 4.7% to real total costs. Accountable factors are changes in cigarette smoking prevalence and in disease-specific mortality and morbidity, as well as a rise in general healthcare expenditure.

Conclusions: Despite the growing knowledge about the hazards of smoking, the smoking-attributable costs increased in Germany. Further, female mortality attributable to smoking is much higher than it was in 1993.

Abbreviations: CPS, Cancer Prevention Survey; ICD, International Classification of Diseases; SAF, smoking-attributable fraction; YPLL, years of potential life lost

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• John, R M, Sung, H-Y, Max, W (2009). Economic cost of tobacco use in India, 2004. Tobacco Control 18: 138-143 [Abstract] [Full Text]  
• Salize, H. J., Merkel, S., Reinhard, I., Twardella, D., Mann, K., Brenner, H. (2009). Cost-effective Primary Care-Based Strategies to Improve Smoking Cessation: More Value for Money. Arch Intern Med 169: 230-235 [Abstract] [Full Text]  
• Gan, Q., Smith, K. R, Hammond, S K., Hu, T.-w. (2007). Disease burden of adult lung cancer and ischaemic heart disease from passive tobacco smoking in China. Tobacco Control 16: 417-422 [Abstract] [Full Text]